DMRA · Damora Therapeutics, Inc. · Fails to Deliver
$28.10
+1.26 (+4.69%)
At close · Sep 11
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.73B
Shares
61.74M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-11 | 9,192 | $29.54 | $271,532 |
| 2026-08-07 | 298 | $29.88 | $8,904 |
| 2026-08-04 | 1,050 | $28.56 | $29,988 |
| 2026-07-30 | 179 | $28.33 | $5,071 |
| 2026-07-29 | 100 | $29.42 | $2,942 |
| 2026-07-28 | 2,164 | $29.44 | $63,708 |
| 2026-07-24 | 4,391 | $29.17 | $128,085 |
| 2026-07-23 | 35,125 | $29.99 | $1,053,399 |
| 2026-07-21 | 97,214 | $32.99 | $3,207,090 |
| 2026-07-20 | 1 | $31.48 | $31 |
| 2026-07-17 | 57 | $30.24 | $1,724 |
| 2026-07-16 | 52 | $30.95 | $1,609 |
| 2026-07-15 | 74 | $30.99 | $2,293 |
| 2026-07-13 | 994 | $28.53 | $28,359 |
| 2026-07-07 | 3,973 | $29.80 | $118,395 |
| 2026-07-02 | 1,971 | $27.09 | $53,394 |
| 2026-07-01 | 563 | $26.01 | $14,644 |
| 2026-06-29 | 571,067 | $25.36 | $14,482,259 |
| 2026-06-25 | 1,132 | $22.00 | $24,904 |
| 2026-06-24 | 1,700 | $22.94 | $38,998 |
| 2026-06-23 | 16,599 | $23.89 | $396,550 |
| 2026-06-22 | 7,247 | $21.23 | $153,854 |
| 2026-06-18 | 4,383 | $21.42 | $93,884 |
| 2026-06-17 | 2,493 | $20.59 | $51,331 |
| 2026-06-15 | 1,556 | $20.78 | $32,334 |
Showing 1–25 of 25 settlements
Key facts
CIK
1800315
CUSIP
G2646Y104
13F (30d)
52 filings
52 filers
Visit website
Investor relations